Tavneos (avacopan) improved kidney function and reduced the need for the glucocorticoid prednisone in four older patients who had…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
Certain clotting markers are found at higher levels in the blood of people with ANCA-associated vasculitis (AAV) when their…
A higher eosinophil count at diagnosis is linked to more severe disease activity in people with microscopic polyangiitis (MPA) or…
Evotec has formed a partnership with Charité – Universitätsmedizin Berlin in Germany to build a database of all sorts…
Factor XII (FXII), a protein involved in blood clotting, is found at significantly higher levels in the blood of people…
ANCA-associated vasculitis (AAV) patients who are older and taking pulses of methylprednisolone as an induction therapy are more likely…
Common variants in genes that encode proteins of the alternative complement pathway, a part of the immune system, may raise…
An 18-month fixed-schedule maintenance regimen of rituximab is better at keeping ANCA-associated vasculitis (AAV) in remission for up to…
A Phase 2 clinical trial testing Q32 Bio’s ADX-097 in people with ANCA-associated vasculitis (AAV) will be the…
Granulomatosis with polyangiitis (GPA) is the most common type of ANCA-associated vasculitis (AAV) in Italy and is linked…